Novel surrogate markers of cardiovascular risk in the setting of autoimmune rheumatic diseases: current data and implications for the future

HIGHLIGHTS

• who: Konstantinos Triantafyllias from the Department of Internal Medicine I, Division of Rheumatology and Clinical Immunology, Johannes Gutenberg University Division of Rheumatology, University and IRCCS Policlinico SMatteo Foundation, Pavia, Italy have published the paper: Novel Surrogate Markers of Cardiovascular Risk in the Setting of Autoimmune Rheumatic Diseases: Current Data and Implications for the Future, in the Journal: (JOURNAL)
• what: Although the research in this field is promising, data focusing specifically on patients with immune-mediated inflammatory diseases is scarce.
• future: As there is a lack of high-quality evidence more studies are needed . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.